Showing results (201-210 of 866) with videos related to

Sort By:
Pageof 87
Zhonghua Yi Xue Za Zhi|November 25, 2010
[Severe fungal corneal ulcer resulting in infectious endophthalmitis]Li-jun Qu, Xiao-guang Dong, Shi-ying Sun, et al.
ACS Applied Materials & Interfaces|October 3, 2017
Organic-Modified Silver Nanoparticles as Lubricant AdditivesChanaka Kumara, Huimin Luo, Donovan N Leonard, et al.
Scientific Reports|March 12, 2014
The sand-deposition impact of artificial gravel beds on the protection of the Mogao GrottoesGuo Shuai Li, Jian Jun Qu, Xu Zhi Li, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 7, 2009
[Mutation analysis of a Chinese family with genetic dentinogenesis imperfecta]Er-jun Qu, Hong-bo Zhang, Lan-ying Chen, et al.
Immunopharmacology and Immunotoxicology|June 25, 2019
Inhibitory effect of rapamycin on proliferation of human umbilical arterial smooth muscle cellsRui Jin, Wei Sun, Yan Bai, et al.
Frontiers in Oncology|November 29, 2023
Choline metabolism and its implications in cancerNan Yao, Wenqiang Li, Guoshuai Xu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 24, 2026
Practical integration of ctDNA-defined minimal residual disease in gastrointestinal cancers: testing windows and evidence-aligned management frameworksNan Yao, Wenqiang Li, Ning Duan, et al.
European Journal of Pharmacology|April 15, 2014
13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13)Shu-Xiang Cui, Hou-Li Zhang, Wen-Fang Xu, et al.
International Journal of Molecular Sciences|March 6, 2021
Potential Neuroprotective Mechanisms of Methamphetamine Treatment in Traumatic Brain Injury Defined by Large-Scale IonStar-Based Quantitative ProteomicsShichen Shen, Ming Zhang, Min Ma, et al.
Pharmacological Research|February 24, 2020
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancerYu-Hang Zhang, Dong-Dong Luo, Sheng-Biao Wan, et al.
Pageof 87